LSL Pharma Group

LSL Pharma Group Current Assets

The Current Assets of LSL Pharma Group (LSL.V) as of Nov 1, 2026 is 12.35 M CAD. In the previous year, Current Assets was 9.22 M CAD — a change of 34.01% (higher).

Current Assets

12.35 MCAD

YoY

34.01%

Last updated:

Current Assets of LSL Pharma Group is 2025 12.35 M CAD. Current Assets of LSL Pharma Group was 2024 9.22 M CAD. It decreases by 34.01% higher compared to the previous year.

The LSL Pharma Group Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2011
210,000.00 CAD
Jan 1, 2012
210,000.00 CAD
Jan 1, 2020
1.64 M CAD
Jan 1, 2021
0.00 CAD
Jan 1, 2022
0.00 CAD
Jan 1, 2023
4.11 M CAD
Jan 1, 2024
9.22 M CAD
Jan 1, 2025
12.35 M CAD
The LSL Pharma Group Current Assets history
YEARCurrent AssetsYoY
12.35 MCAD+34.01%
9.22 MCAD+124.29%
4.11 MCAD—
0.00CAD—
0.00CAD-100.00%
1.64 MCAD+680.66%
210,000.00CAD0.00%
210,000.00CAD+10.53%
190,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

LSL Pharma Group Stock analysis

What does LSL Pharma Group do? LSL Pharma Group, Inc. generates revenue through the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The company operates as a pharmaceutical entity specializing in these specific therapeutic and wellness categories to meet market demand. The firm utilizes its subsidiaries, including Steri-Med Pharma Inc., LSL Laboratory Inc., and Groupe Immobilier LSL inc., to support its core operations. These entities facilitate the company's ability to produce and distribute its specialized pharmaceutical and supplement offerings effectively within its operational framework. LSL Pharma Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LSL Pharma Group stock

Current Assets of LSL Pharma Group is 12.35 M CAD in 2025.

Current Assets of LSL Pharma Group changed from 9.22 M CAD to 12.35 M CAD, representing a 34.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets LSL Pharma Group since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's LSL Pharma Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — LSL Pharma Group

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — LSL Pharma Group